PTPN22 Association in Systemic Lupus Erythematosus (SLE) with Respect to Individual Ancestry and Clinical Sub-Phenotypes

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Namjou, Bahram ^a,b   Kim Howard, Xana ^a   Sun, Celi ^a   Adler, Adam ^a   Chung, Sharon A ^c   Kaufman, Kenneth M ^b,d   Kelly, Jennifer A ^a   Glenn, Stuart B ^a   Guthridge, Joel M ^a   Scofield, Robert H ^a,e   Kimberly, Robert P ^f   Brown, Elizabeth E ^f   Alarcón, Graciela S ^f   Edberg, Jeffrey C ^f   Kim, Jae Hoon ^g   Choi, Jiyoung ^g   Ramsey Goldman, Rosalind ^h   Petri, Michelle A ⁱ   Reveille, John D ^j   Vilá, Luis M ^k   Boackle, Susan A ^l   Freedman, Barry I ^m   Tsao, Betty P ⁿ   Langefeld, Carl D ^m   Vyse, Timothy J ^o   Jacob, Chaim O ^p   Pons Estel, Bernardo ^q   Niewold, Timothy B ^r   Moser Sivils, Kathy L ^a   Merrill, Joan T ^a   Anaya, Juan Manuel ^s   Gilkeson, Gary S ^t   Gaffney, Patrick M ^a   Bae, Sang Cheol ^g   Alarcón Riquelme, Marta E ^a,u   Harley, John B ^b,d   Criswell, Lindsey A ^c   James, Judith A ^a,e   Nath, Swapan K ^a   more..

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^f University of Alabama at Birmingham   (United States)

^g Hanyang University Hospital for Rheumatic Diseases   (South Korea)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^k UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^l UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^m WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o KING'S COLLEGE LONDON   (United Kingdom)

^p UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^q Sanatorio Parque   (Argentina)

^r MAYO GRADUATE SCHOOL   (United States)

^s UNIVERSIDAD DEL ROSARIO   (Colombia)

^t MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^u UNIVERSITY OF GRANADA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22;

AFRICAN AMERICAN; ANTIBODY TITER; ARTICLE; ASIAN; CONTROLLED STUDY; ETHNICITY; EUROPEAN AMERICAN; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HISPANIC; HUMAN; INTRON; MAJOR CLINICAL STUDY; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PHENOTYPIC VARIATION; POPULATION BASED CASE CONTROL STUDY; PTPN22 GENE; QUANTITATIVE ANALYSIS; QUANTITATIVE TRAIT LOCUS; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

AFRICAN AMERICANS; ANTIBODIES, ANTICARDIOLIPIN; ASIAN AMERICANS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HISPANIC AMERICANS; HUMANS; IMMUNOGLOBULIN G; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22;

EID: 84881329854     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069404     Document Type: Article

References (64)

1. Kyogoku C, Langefeld CD, Ortmann WA, Lee A, Selby S, et al. (2004) Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 75: 504-507.
2. SLEGEN Harley JB, Alarcon-Riquelme ME, Criswell LA, Jacob CO, et al. (2008) Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40: 204-210.
3. Kaufman KM, Kelly JA, Herring BJ, Adler AJ, Glenn SB, et al. (2006) Evaluation of the genetic association of the PTPN22 R620W polymorphism in familial and sporadic systemic lupus erythematosus. Arthritis Rheum 54: 2533-2540.
4. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, et al. (2004) A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 36: 337-338.
5. Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, et al. (2004) A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 75: 330-337.
6. Hinks A, Barton A, John S, Bruce I, Hawkins C, et al. (2005) Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene. Arthritis Rheum 52: 1694-1699.
7. Dultz G, Matheis N, Dittmar M, Bender K, Kahaly GJ, (2009) CTLA-4 CT60 polymorphism in thyroid and polyglandular autoimmunity. Horm Metab Res 41: 426-429.
8. Jagiello P, Aries P, Arning L, Wagenleiter SE, Csernok E, et al. (2005) The PTPN22 620W allele is a risk factor for Wegener's granulomatosis. Arthritis Rheum 52: 4039-4043.
9. Vandiedonck C, Capdevielle C, Giraud M, Krumeich S, Jais JP, et al. (2006) Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis. Ann Neurol 59: 404-407.
10. Criswell LA, Pfeiffer KA, Lum RF, Gonzales B, Novitzke J, et al. (2005) Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 76: 561-571.
11. Velaga MR, Wilson V, Jennings CE, Owen CJ, Herington S, et al. (2004) The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab 89: 5862-5865.
12. Skinningsrud B, Husebye ES, Gervin K, Lovas K, Blomhoff A, et al. (2008) Mutation screening of PTPN22: association of the 1858T-allele with Addison's disease. Eur J Hum Genet 16: 977-982.
13. Diaz-Gallo LM, Gourh P, Broen J, Simeon C, Fonollosa V, et al. (2011) Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis. Ann Rheum Dis 70: 454-462.
14. Canton I, Akhtar S, Gavalas NG, Gawkrodger DJ, Blomhoff A, et al. (2005) A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo. Genes Immun 6: 584-587.
15. Siminovitch KA, (2004) PTPN22 and autoimmune disease. Nat Genet 36: 1248-1249.
16. Gomez LM, Anaya JM, Gonzalez CI, Pineda-Tamayo R, Otero W, et al. (2005) PTPN22 C1858T polymorphism in Colombian patients with autoimmune diseases. Genes Immun 6: 628-631.
17. Vang T, Congia M, Macis MD, Musumeci L, Orru V, et al. (2005) Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 37: 1317-1319.
18. Gregersen PK, Lee HS, Batliwalla F, Begovich AB, (2006) PTPN22: setting thresholds for autoimmunity. Semin Immunol 18: 214-223.
19. Lee YH, Rho YH, Choi SJ, Ji JD, Song GG, et al. (2007) The PTPN22 C1858T functional polymorphism and autoimmune diseases-a meta-analysis. Rheumatology (Oxford) 46: 49-56.
20. Arechiga AF, Habib T, He Y, Zhang X, Zhang ZY, et al. (2009) Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling. J Immunol 182: 3343-3347.
21. Pradhan V, Borse V, Ghosh K, (2010) PTPN22 gene polymorphisms in autoimmune diseases with special reference to systemic lupus erythematosus disease susceptibility. J Postgrad Med 56: 239-242.
22. Menard L, Saadoun D, Isnardi I, Ng YS, Meyers G, et al. (2011) The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. J Clin Invest 121: 3635-3644.
23. Burn GL, Svensson L, Sanchez-Blanco C, Saini M, Cope AP, (2011) Why is PTPN22 a good candidate susceptibility gene for autoimmune disease? FEBS Lett.
24. Brownlie RJ, Miosge LA, Vassilakos D, Svensson LM, Cope A, et al. (2012) Lack of the phosphatase PTPN22 increases adhesion of murine regulatory T cells to improve their immunosuppressive function. Sci Signal 5: ra87.
25. Gianchecchi E, Palombi M, Fierabracci A, (2012) The putative role of the C1858T polymorphism of protein tyrosine phosphatase PTPN22 gene in autoimmunity. Autoimmun Rev.
26. Manjarrez-Orduno N, Marasco E, Chung SA, Katz MS, Kiridly JF, et al. (2012) CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation. Nat Genet 44: 1227-1230.
27. Vang T, Landskron J, Viken MK, Oberprieler N, Torgersen KM, et al. (2013) The autoimmune-predisposing variant of lymphoid tyrosine phosphatase favors T helper 1 responses. Hum Immunol.
28. Reddy MV, Johansson M, Sturfelt G, Jonsen A, Gunnarsson I, et al. (2005) The R620W C/T polymorphism of the gene PTPN22 is associated with SLE independently of the association of PDCD1. Genes Immun 6: 658-662.
29. Petri M, Perez-Gutthann S, Longenecker JC, Hochberg M, (1991) Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med 91: 345-353.
30. Reveille JD, Moulds JM, Ahn C, Friedman AW, Baethge B, et al. (1998) Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum 41: 1161-1172.
31. Fernandez M, Alarcon GS, Calvo-Alen J, Andrade R, McGwin G Jr, et al. (2007) A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum 57: 576-584.
32. Mori M, Yamada R, Kobayashi K, Kawaida R, Yamamoto K, (2005) Ethnic differences in allele frequency of autoimmune-disease-associated SNPs. J Hum Genet 50: 264-266.
33. Totaro MC, Tolusso B, Napolioni V, Faustini F, Canestri S, et al. (2011) PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis. PLoS One 6: e24292.
34. Kim K, Brown EE, Choi CB, Alarcon-Riquelme ME, Kelly JA, et al. (2012) Variation in the ICAM1-ICAM4-ICAM5 locus is associated with systemic lupus erythematosus susceptibility in multiple ancestries. Ann Rheum Dis 71: 1809-1814.
35. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, et al. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-1277.
36. Hochberg MC, (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725.
37. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, et al. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 106: 9362-9367.
38. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, et al. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38: 904-909.
39. Cooper GS, Parks CG, Treadwell EL, St Clair EW, Gilkeson GS, et al. (2002) Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States. Lupus 11: 161-167.
40. Pritchard JK, Rosenberg NA, (1999) Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet 65: 220-228.
41. Lessard CJ, Adrianto I, Kelly JA, Kaufman KM, Grundahl KM, et al. (2011) Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study. Am J Hum Genet 88: 83-91.
42. Yang Li, Ding J, Abecasis GR, (2006) Mach 1.0: Rapid Haplotype Reconstruction and Missing Genotype Inference. Am J Hum Genet S79: 2290.
43. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
44. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
45. Purcell S, Daly MJ, Sham PC, (2007) WHAP: haplotype-based association analysis. Bioinformatics 23: 255-256.
46. Harris EN, Gharavi AE, Patel SP, Hughes GR, (1987) Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 68: 215-222.
47. Zeller T, Wild P, Szymczak S, Rotival M, Schillert A, et al. (2010) Genetics and beyond-the transcriptome of human monocytes and disease susceptibility. PLoS One 5: e10693.
48. Lea W, Lee Y, (2011) The association between the PTPN22 C1858T polymorphism and systemic lupus erythematosus: a meta-analysis update. Lupus 20: 51-57.
49. Orozco G, Sanchez E, Gonzalez-Gay MA, Lopez-Nevot MA, Torres B, et al. (2005) Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 52: 219-224.
50. Piotrowski P, Lianeri M, Wudarski M, Lacki JK, Jagodzinski PP, (2008) Contribution of the R620W polymorphism of protein tyrosine phosphatase non-receptor 22 to systemic lupus erythematosus in Poland. Clin Exp Rheumatol 26: 1099-1102.
51. Sanchez E, Comeau ME, Freedman BI, Kelly JA, Kaufman KM, et al. (2011) Identification of novel genetic susceptibility loci in African-American lupus patients using a candidate gene association study. Arthritis Rheum 63: 3493-3501.
52. Han JW, Zheng HF, Cui Y, Sun LD, Ye DQ, et al. (2009) Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 41: 1234-1237.
53. Behrens TW, (2011) Lyp breakdown and autoimmunity. Nat Genet 43: 821-822.
54. Zhang J, Zahir N, Jiang Q, Miliotis H, Heyraud S, et al. (2011) The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness. Nat Genet 43: 902-907.
55. Dai X, James RG, Habib T, Singh S, Jackson S, et al. (2013) A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models. J Clin Invest 123: 2024-2036.
56. Cambier JC, (2013) Autoimmunity risk alleles: hotspots in B cell regulatory signaling pathways. J Clin Invest 123: 1928-1931.
57. Smith RL, Warren RB, Eyre S, Ke X, Young HS, et al. (2008) Polymorphisms in the PTPN22 region are associated with psoriasis of early onset. Br J Dermatol 158: 962-968.
58. Curtin K, Wong J, Allen-Brady K, Camp NJ, (2007) Meta-genetic association of rheumatoid arthritis and PTPN22 using PedGenie 2.1. BMC Proc 1 Suppl 1: S12.
59. Yoo YJ, Gao G, Zhang K, (2007) Case-control association analysis of rheumatoid arthritis with candidate genes using related cases. BMC Proc 1 Suppl 1: S33.
60. Rodriguez-Rodriguez L, Taib WR, Topless R, Steer S, Gonzalez-Escribano MF, et al. (2011) The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples. Arthritis Rheum 63: 365-372.
61. Orru V, Tsai SJ, Rueda B, Fiorillo E, Stanford SM, et al. (2009) A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus. Hum Mol Genet 18: 569-579.
62. Ploski R, Dziunycz P, Kostrzewa G, Roszkowski PI, Barcz E, et al. (2009) PTPN22/LYP 1858C>T gene polymorphism and susceptibility to endometriosis in a Polish population. J Reprod Immunol 79: 196-200.
63. Drenkard C, Villa AR, Alarcon-Segovia D, Perez-Vazquez ME, (1994) Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus. J Rheumatol 21: 1067-1072.
64. McClain MT, Arbuckle MR, Heinlen LD, Dennis GJ, Roebuck J, et al. (2004) The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus. Arthritis Rheum 50: 1226-1232.